Balance Sheet

Cash Flow Statement

Acquisitions Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Cavco Industries (CVCO) Asset Writedowns and Impairment (2025)

Cavco Industries has reported Asset Writedowns and Impairment over the past 3 years, most recently at $10.0 million for Q1 2025.

Quarterly Asset Writedowns and Impairment changed N/A to $10.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Mar 2025, changed N/A year-over-year, with the annual reading at $10.0 million for FY2025, N/A changed from the prior year.
Asset Writedowns and Impairment was $10.0 million for Q1 2025 at Cavco Industries, up from $269000.0 in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $10.0 million in Q1 2025 and troughed at $10.0 million in Q1 2025.